Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Clinical Advances in Hematology & Oncology : H&O
|
June 12, 2026
Addressing late detection of systemic relapse, the clinical blind spot
Fengting Yan
Frontiers in Oncology
|
November 24, 2025
Editorial: Case reports in breast cancer 2023-2024
Fengting Yan, Min Sun, Henry Kaplan
Clinical Breast Cancer
|
July 5, 2023
Newly Approved and Emerging Agents in HER2-Positive Metastatic Breast Cancer
Stephanie L Graff, Fengting Yan, Yara Abdou
Pharmaceuticals (Basel, Switzerland)
|
March 14, 2017
Targeted Drugs as Maintenance Therapy after Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma
Fengting Yan, Ajay K Gopal, Solomon A Graf
Clinical Advances in Hematology & Oncology : H&O
|
June 12, 2026
Molecular residual disease (MRD) testing: advancing clinical decision-making in breast cancer
Jason A Mouabbi, Marla D Lipsyc-Sharf, Fengting Yan
Clinical Advances in Hematology & Oncology : H&O
|
June 12, 2026
Practical approach to MRD testing in breast cancer: Q&A
Jason A Mouabbi, Marla D Lipsyc-Sharf, Fengting Yan
Scientific Reports
|
February 19, 2025
A rapid and precise algorithm for maize leaf disease detection based on YOLO MSM
Yu Meng, Jiawei Zhan, Kangshun Li, et al.
Entropy (Basel, Switzerland)
|
June 28, 2023
A Hybrid Parallel Balanced Phasmatodea Population Evolution Algorithm and Its Application in Workshop Material Scheduling
Song Han, Shanshan Chen, Fengting Yan, et al.
Frontiers in Oncology
|
September 2, 2024
Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series
Reshma Mahtani, Natasha Harpalani, Fengting Yan, et al.
Zhonghua Fu Chan Ke Za Zhi
|
April 16, 2002
[Effect of cyclosporin A on the growth of human first trimester cytotrophoblasts in vitro]
Fengting Yan, Dajin Li, Xiaoxi Sun, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Clinical Advances in Hematology & Oncology : H&O
|
June 12, 2026
Addressing late detection of systemic relapse, the clinical blind spot
Fengting Yan
Frontiers in Oncology
|
November 24, 2025
Editorial: Case reports in breast cancer 2023-2024
Fengting Yan, Min Sun, Henry Kaplan
Clinical Breast Cancer
|
July 5, 2023
Newly Approved and Emerging Agents in HER2-Positive Metastatic Breast Cancer
Stephanie L Graff, Fengting Yan, Yara Abdou
Pharmaceuticals (Basel, Switzerland)
|
March 14, 2017
Targeted Drugs as Maintenance Therapy after Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma
Fengting Yan, Ajay K Gopal, Solomon A Graf
Clinical Advances in Hematology & Oncology : H&O
|
June 12, 2026
Molecular residual disease (MRD) testing: advancing clinical decision-making in breast cancer
Jason A Mouabbi, Marla D Lipsyc-Sharf, Fengting Yan
Clinical Advances in Hematology & Oncology : H&O
|
June 12, 2026
Practical approach to MRD testing in breast cancer: Q&A
Jason A Mouabbi, Marla D Lipsyc-Sharf, Fengting Yan
Scientific Reports
|
February 19, 2025
A rapid and precise algorithm for maize leaf disease detection based on YOLO MSM
Yu Meng, Jiawei Zhan, Kangshun Li, et al.
Entropy (Basel, Switzerland)
|
June 28, 2023
A Hybrid Parallel Balanced Phasmatodea Population Evolution Algorithm and Its Application in Workshop Material Scheduling
Song Han, Shanshan Chen, Fengting Yan, et al.
Frontiers in Oncology
|
September 2, 2024
Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series
Reshma Mahtani, Natasha Harpalani, Fengting Yan, et al.
Zhonghua Fu Chan Ke Za Zhi
|
April 16, 2002
[Effect of cyclosporin A on the growth of human first trimester cytotrophoblasts in vitro]
Fengting Yan, Dajin Li, Xiaoxi Sun, et al.
Page
of 3